Article
AMO acquires IntraLase
The acquisition of IntraLase Corp. by Advanced Medical Optics (AMO), announced Jan. 9, joins two of the strongest performers in the refractive surgery market. The $808 million cash transaction may be the impetus for a change in how the traditional microkeratome is viewed among refractive surgeons.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
